AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Gregory J. Aune, MD, PhD, is a renowned pediatric oncologist with a powerful story. At age 16, he was...
June 2022 marked the 10th Annual Cancer Immunotherapy Month spearheaded by the Cancer Research Institute. Immunotherapy is an umbrella...
Although childhood cancer is rare, it represents the leading cause of death by disease in children in developed countries....
As we celebrate National Cancer Survivor Month, we are aware how the term survivor can take on many meanings...
From June 23-26, researchers from around the world will gather in Boston for the Third AACR International Meeting on...
Karriem Watson is a public health expert serving as chief engagement officer of the National Institutes of Health’s All...
As the first AACR Annual Meeting held in person after the pandemic was coming to a close, the last...
Since COVID-19 first began its siege on the world, much of our scientific knowledge about the disease—and its source...
At the age of 40, Marlena Murphy was diagnosed with triple-negative breast cancer, an aggressive subtype that occurs twice...
For the past several decades, researchers have been harnessing the power of the immune system to fight cancer. They...